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Abstract
Candida albicans is an important opportunistic fungal pathogen of immunocompromised individuals. One critical virulence
attribute is its morphogenetic plasticity. Hyphal development requires two temporally linked changes in promoter
chromatin, which is sequentially regulated by temporarily clearing the transcription inhibitor Nrg1 upon activation of the
cAMP/PKA pathway and promoter recruitment of the histone deacetylase Hda1 under reduced Tor1 signaling. Molecular
mechanisms for the temporal connection and the link to Tor1 signaling are not clear. Here, through a forward genetic
screen, we report the identification of the GATA family transcription factor Brg1 as the factor that recruits Hda1 to
promoters of hypha-specific genes during hyphal elongation. BRG1 expression requires both the removal of Nrg1 and a sub-
growth inhibitory level of rapamycin; therefore, it is a sensitive readout of Tor1 signaling. Interestingly, promoters of hypha-
specific genes are not accessible to Brg1 in yeast cells. Furthermore, ectopic expression of Brg1 cannot induce hyphae, but
can sustain hyphal development. Nucleosome mapping of a hypha-specific promoter shows that Nrg1 binding sites are in
nucleosome free regions in yeast cells, whereas Brg1 binding sites are occupied by nucleosomes. Nucleosome disassembly
during hyphal initiation exposes the binding sites for both regulators. During hyphal elongation, Brg1-mediated Hda1
recruitment causes nucleosome repositioning and occlusion of Nrg1 binding sites. We suggest that nucleosome
repositioning is the underlying mechanism for the yeast-hyphal transition. The hypha-specific regulator Ume6 is a key
downstream target of Brg1 and functions after Brg1 as a built-in positive feedback regulator of the hyphal transcriptional
program to sustain hyphal development. With the levels of Nrg1 and Brg1 dynamically and sensitively controlled by the two
major cellular growth pathways, temporal changes in nucleosome positioning during the yeast-to-hypha transition provide
a mechanism for signal integration and cell fate specification. This mechanism is likely used broadly in development.
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Introduction
Candida albicans is a major opportunistic fungal pathogen of
humans [1,2]. In most healthy individuals C. albicans exists as a
harmless commensal in the oral cavity and the gastrointestinal and
urogenital tracts. But the fungus can cause mucosal infections and
systemic disease in immunocompromised people. One critical
virulence attribute of C. albicans is its ability to undergo hyphal
development in response to environmental cues. Mutants that are
defective in hyphal formation display much reduced virulence in
animal models of systemic candidiasis [3,4]. Hyphal morphogenesis
is coupled with virulence as genes that control hyphal morphology
are co-regulated with genes encoding virulence factors such as
proteases and adhesins [4]. For example, HWP1, ALS3, and RBT5
encodecellwallproteinsthatareimportantforadhesiontohostcells
and iron acquisition from the host [5–8]. The transcription factor
Ume6, specifically expressed during hyphal development, controls
the level and duration of hypha-specific genes and is important for
hyphal elongation [9–11]. Hyphal morphogenesis and cell chain
formation are under the control of another hypha-specific gene that
encodes the G1 cyclin-related protein Hgc1 [12–16].
Hyphal development is regulated by multiple signal transduc-
tion pathways. Among them, the cAMP-dependent protein kinase
A (PKA) pathway is essential for morphogenesis and virulence
[17]. We recently showed that activation of the hyphal
transcriptional program involves two phases of temporal dynamic
changes in promoter chromatin [18]. Initiation requires a rapid
but temporary disappearance of Nrg1, a major repressor of hyphal
morphogenesis [19,20], via activation of the cAMP-PKA pathway
[18]. Nrg1 disappearance from the promoters of hypha-specific
genes is correlated with dissociation of the Rpd3 histone
deacetylase from the promoters, increase in H4 acetylation,
nucleosome disassembly, and transcriptional activation. Mainte-
nance requires the recruitment of the Hda1 histone deacetylase to
promoters under reduced Tor1 (target of rapamycin) signalling
[18]. Hda1 deacetylates a subunit of the NuA4 histone
acetyltransferase module, leading to eviction of the NuA4
acetyltransferase module and chromatin remodelling that blocks
Nrg1 access to the promoters of hypha-specific genes. Promoter
recruitment of Hda1 for hyphal maintenance happens only during
the period when Nrg1 is gone. Such temporally linked regulation
of promoter chromatin provides a unique mechanism for
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and phenotypic plasticity during hyphal development.
C. albicans contains a conserved Tor1 protein kinase [21,22].
Gln3 and Gat1, two GATA family transcription activators for
genes that are subject to nitrogen catabolite repression, are targets
of the TOR kinases in Saccharomyces cerevisiae [23]. Their homologs
in C. albicans [24,25], however, are not important for hyphal
maintenance. The transcription factor that recruits Hda1 to the
promoters of hypha-specific genes has not been identified.
Furthermore, the molecular mechanism for the temporal connec-
tion between hyphal initiation and elongation is not clear. Here,
we report, through a forward genetic screen the identification of
the GATA family transcription factor Gat2, recently found as a
biofilm regulator Brg1 [26], as the one that recruits Hda1 to
promoters of hypha-specific genes. BRG1 expression is a sensitive
readout of Tor1 signalling level in C. albicans, and Brg1 expression
during hyphal elongation leads to nucleosome repositioning.
Different nucleosome positions at the promoters of hypha-specific
genes lead to different accessibility of Nrg1 and Brg1 to their
DNA-binding sites at the promoters. This provides molecular
insights to the sequential and integrative nature of promoter
chromatin regulation. We further show that Brg1 functions before
Ume6 in a feed-forward loop that regulates the yeast-to-hypha
transition in C. albicans.
Results
Brg1 is required for promoter recruitment of Hda1 under
reduced Tor1 signaling during hyphal elongation
To uncover how rapamycin regulates hyphal elongation, we
used a forward genetic screen to identify transcription factors
responsible for recruitment of Hda1 under reduced Tor1
signaling. Based on the phenotype of the hda1 mutant, we
expected the mutants of interest to be capable of germ-tube
formation, but defective in sustained hyphal growth. Furthermore,
they were expected to block rapamycin-mediated hyphal elonga-
tion. Mutants defective in hyphal elongation, but with defects
which could be suppressed by rapamycin, were not studied further
as their gene products were expected to act upstream or parallel to
Tor1 signaling. We screened a knockout library of 165
transcription factor genes in C. albicans [27] for mutants defective
in hyphal elongation in the presence of rapamycin. Only 8
mutants showed defects to varying extents in hyphal elongation in
the presence of rapamycin, and could form germ tubes during
hyphal initiation (Table 1). Among the 8 mutants, we found that
promoter recruitment of Hda1 in the presence of rapamycin was
Author Summary
Candida is part of the gut microflora in healthy individuals,
but can disseminate and cause systemic disease when the
host’s immune system is suppressed. Its ability to grow as
yeast and hyphae in response to environmental cues is a
major virulence attribute. Hyphal development requires
temporary clearing of the transcription inhibitor Nrg1
upon activation of cAMP/PKA for initiation and promoter
recruitment of the histone deacetylase Hda1 under
reduced Tor1 signaling for maintenance. Here, we show
that, during hyphal initiation when Nrg1 is gone,
expression of the GATA family transcription factor Brg1 is
activated under reduced Tor1 signaling. Accumulated Brg1
recruits Hda1 to hyphal promoters to reposition nucleo-
somes, leading to obstruction of Nrg1 binding sites and
sustained hyphal development. The nucleosome reposi-
tioning during the yeast-hyphal transition provides a
mechanism for temporal integration of extracellular signals
and cell-fate specification. The hypha-specific transcription
factor Ume6 functions after Brg1 in this succession of feed-
forward regulation of hyphal development. Since mis-
regulation of either Nrg1 or Ume6 causes altered virulence,
and Brg1 regulates both Nrg1 accessibility and Ume6
transcription, our findings should provide a better
understanding of how Candida controls its morphological
program in different host niches to exist as a commensal
and a pathogen.






Wild type +++++ +++++
NTO1 Subunit of the NuA3 histone acetyltransferase complex that acetylates histone
H3; contains PHD finger domain that interacts with methylated histone H3
+++++ +++
GIS2 Putative transcription factor; expression is increased in high iron and reduced upon yeast-hyphal
switch; null mutant exhibits sensitivity to sorbitol, 5-fluorocytosine, and cold temperatures
+++++ +++
ASH1 GATA-like transcription factor; localizes to nuclei of daughter cells and hyphal tip cells; mRNA
localization is mediated by binding to She3p; required for wild-type virulence and filamentous growth
+++++ +++
BRG1 Putative DNA-binding transcription factor; similar to S. cerevisiae Gat2p; transposon
mutation affects filamentous growth
+++++ +
ASG1 Gal4p family zinc-finger transcription factor with similarity to S. cerevisiae Asg1p +++++ ++
ROB1 Putative protein of unknown function; null mutant displays abnormal colony morphology
and invasive growth; caspofungin repressed
+++ +
AHR1 Zinc-finger transcription factor involved in regulation of adhesion genes; involved in
white-opaque switch; forms complex with Mcm1p; null mutant displays sensitivity
to 5-fluorocytosine and to lithium chloride
++ +
BCR1 C2H2 zinc finger transcription factor required for wild-type biofilm formation; mutation
affects filamentous growth; regulates cell-surface-associated genes; filament induced;
Tup1p-, Tec1p-, Mnl1p-regulated; mRNA binds to She3p
+++ ++
*All descriptions are from the Candida Genome Database. + indicates levels of filamentation.
doi:10.1371/journal.ppat.1002663.t001
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the wild-type strain by chromatin immunoprecipitation (ChIP)
(Figure 1A), and Hda1 protein levels were not reduced in those
mutants (data not shown). Because promoter recruitment of Hda1
could only be established within the time window of reduced Nrg1
[18], any defects in Nrg1 down-regulation would also block Hda1
recruitment. To exclude this possibility, a Western of Nrg1-Myc
was performed in these three mutants. Nrg1 protein level
decreased sharply in the brg1 mutant at 30 min upon hyphal
induction as in the wild-type strain. But no obvious change in
Nrg1 level was observed in the rob1 or ahr1 mutant (Figure 1B).
This is consistent with the efficient germ tube formation (,90%)
observed in brg1 cells (Figure 1C). The brg1 mutant showed a
similar defect in hyphal elongation and Hda1 promoter recruit-
ment in response to serum (Figure S1). The Brg1-dependent Hda1
recruitment to the UAS region of HWP1 is shown in Figure 1A,
and to the UAS regions of ALS3 and ECE1 shown in Figure S2.
Therefore, Brg1 is the only transcription factor specifically
required for the recruitment of Hda1 to hypha-specific promoters,
but not involved in Nrg1 down-regulation during hyphal initiation.
Previous genome-wide mutant screens have identified Brg1 as a
general positive regulator of morphogenesis [27] and a brg1
mutant carrying a transposon insertion proximal to the ORF was
found to be hyperfilamentous [28]. Our results provide a
molecular function of Brg1 in filamentous growth.
C. albicans Brg1 is most homologous in protein sequence to S.
cerevisiae Gat2 by BLAST analysis. Both proteins contain a GATA
family zinc finger motif most similar to Gat3, Gat4, Gat1 and
Gln3 of S. cerevisiae. Functions and regulations of Gat2, Gat3, and
Gat4 in S. cerevisiae are not well studied. Gln3 and Gat1 are
phosphorylated by the TOR kinases [23], and sequestered in the
cytoplasm. In response to rapamycin treatment, Gln3 and Gat1
increasingly accumulate in the nucleus, where they bind to DNA
and activate transcription of nitrogen catabolite repression-
sensitive genes [29]. To examine if Brg1 accumulates in the
nucleus in response to reduced Tor1 signaling, we localized Brg1
by indirect immunofluorescence. Brg1 was tagged at its N
terminus with 13 Myc, and its expression was under the control
of the MAL2 promoter. Unlike Gln3 and Gat1, Myc-Brg1
displayed nuclear localization under all conditions with or without
rapamycin (Figure S3).
Brg1 interacts with Hda1 and binds to the promoters of
hypha-specific genes in a rapamycin-dependent manner
To determine if Brg1 interacts with Hda1, Hda1 was fused at its
C-terminus with a TAP tag of two copies of protein A sequence
followed by calmodulin binding protein [30]. Using strains
carrying the Myc-Brg1 under the MAL2 promoter, we found that
immunoprecipitation of Hda1 with IgG beads was able to pull
down Myc-Brg1 (Figure 2A). The interaction was not regulated by
growth forms, and was independent of rapamycin and tempera-
ture (Figure 2A).
Since Brg1 is the transcription factor required for the promoter
recruitment of Hda1 and it interacts with Hda1 in vivo,w e
anticipated that Brg1 directly binds to the promoters of hypha-
specific genes. We tagged Brg1 at the C-terminus with 13 Myc
under its endogenous promoter for Brg1 ChIP experiments and
performed a time course ChIP during hyphal induction. Brg1-myc
was not detected at the promoters of hypha-specific genes in yeast
cells from the starting culture. During hyphal growth at 37uC,
Brg1-myc became associated with the UAS regions of the hypha-
specific promoters in a rapamycin-dependent manner (Figure 2B),
very similar to rapamycin-dependent promoter recruitment of
Hda1 [18]. Our results suggest that Brg1 recruits Hda1 to hyphal
gene promoters to sustain hyphal development. This Tor1-
mediated regulation could be at the level of Brg1 expression,
stability, and/or promoter binding.
Removal of Nrg1 inhibition and rapamycin are both
required for BRG1 expression
We next examined whether Brg1 protein levels changed in
response to rapamycin. The protein level of Brg1-myc under its
endogenous promoter was low, but detectable in cells from
overnight cultures. It increased rapidly at 1 h upon hyphal
induction at 37uC and stayed at a high level in rapamycin-
containing medium during hyphal elongation, but returned to a
low level in the absence of rapamycin (Figure S4A), suggesting that
Figure 1. brg1 is the only mutant found to be defective in Hda1
promoter recruitment. (A). ChIP of Hda1-Myc in mutants defective in
hyphal elongation. Wild type and indicated mutant cells carrying Hda1-
Myc were diluted into YPD+10 nM rapamycin medium at 37uC for 6 h.
ChIP DNA was quantitated as described [18] by qPCR with primers at
the UAS region of HWP1 [30]. The 0 h values of wild type cells were set
to be 1.00. The ChIP data show the average of three independent qPCR
experiments with error bars representing the SEM. (B) Western analysis
of Nrg1-Myc. brg1, rob1, and ahr1 mutant cells carrying Nrg1-Myc were
diluted into YPD medium at 37uC for 30 min. (C). Overnight cultures of
wild type (SN250) and brg1 mutant were diluted 1:250 fold into YPD
medium at 37uC. 5 nM rapamycin was added after 1 hour to YPD
medium. Cells were collected at 0 h, 1 h, and 6 h for cell morphology
analysis.
doi:10.1371/journal.ppat.1002663.g001
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Brg1 expression. However, rapamycin alone was not sufficient for a
high level of Brg1, as Brg1 levels were low at 25uC even in the
presence of rapamycin (Figure S4A). Brg1 protein was unstable, but
its stability was not regulated by temperature or rapamycin (Figure
S3B). This suggested that rapamycin-dependent accumulation of
Brg1 protein likely reflected the transcriptional regulation of BRG1
by the Tor1 pathway. Similar to its protein levels, we found that
BRG1 expression was activated by a shift in temperature to 37uC
and maintained at a high level in the presence of rapamycin
(Figure 3A). In the absence of rapamycin, BRG1 expression level
increased briefly when cells were inoculated to YPD at 37uC, but
decreased afterwards (Figure 3A). BRG1 expression level remained
low at 25uC regardless of the presence of rapamycin. Since Nrg1 is
temporarily cleared when cells are inoculated into fresh medium at
37uC [18], a prerequisite condition for the induction in BRG1
expression, we examined whether the down-regulation of Nrg1 is
essential for the activation of BRG1 expression. We found that
ectopic expression of NRG1 under the MAL2 promoter completely
blocked the induction of BRG1 in YPD medium with rapamycin at
37uC (Figure S5). Furthermore, rapamycin could induce BRG1
expression independent of temperature in an nrg1 mutant
(Figure 3B). These results suggest that Nrg1 removal is required
for rapamycin-induced BRG1 expression during hyphal elongation.
Unlike hyphal genes, BRG1 transcript or Brg1 protein is present in
the starting yeast cell, although at a low level. Furthermore,
removing Nrg1 inhibition is not sufficient for the induction of BRG1
expression, as BRG1 transcript levels at time 0 were similar between
the nrg1 mutant and the wild-type strain (Figure 3B vs. 3A. the value
at time 0 in A was set to 1 and used for normalization in both A and
B), and BRG1 cannot be induced in the nrg1 mutant in the absence
of rapamycin (Figure 3B). Therefore, relief of Nrg1 inhibition by the
activation of the cAMP/PKA pathway and reduced Tor1 signaling
are both required for BRG1 expression; neither one is sufficient.
Similar to hypha-specific genes, we predicted that Nrg1 and
Brg1 can bind to the BRG1 promoter, and Brg1 recruitment of
Hda1 can remodel the promoter chromatin to block Nrg1 from
binding onto the BRG1 promoter during hyphal elongation. Nrg1
has been reported to bind to [A/C][A/C/G]CCCT, CCCCT or
CCCT/C containing sequences [20] and Brg1 binds to the DNA
sequence [A/C]GGTA[C/A] [26]. We analyzed the intergenic
region upstream of BRG1 (,10 kb) and found 3 regions of
,250 bp long that contain binding motifs for both Nrg1 and Brg1
(Figure S6). The ChIP DNA of Nrg1-Myc at time 0 (yeast cells)
and Brg1-Myc at 6 h in the presence of rapamycin at 37uC
(hyphal cells) were analyzed by qPCR at these regions (Figure S6).
Among them, the region 21959,21710 bp showed much higher
ChIP signals for both Nrg1-Myc and Brg1-Myc than the other
regions (Figure S6). This region was therefore considered as a
potential UAS region for BRG1, and was used for subsequent
ChIP time course experiments. As expected, Nrg1 dissociated
rapidly from the BRG1 promoter during hyphal initiation and
remained unbound in a rapamycin-dependent manner; Brg1
bound to the promoter in the presence of rapamycin only during
hyphal elongation (Figure 3CD), similar to its temporal association
with the promoters of hypha-specific genes.
Ectopically expressed Brg1 can bind to the promoters of
many hypha-specific genes independent of rapamycin,
while binding to its own promoter is rapamycin-
dependent
In strains carrying Brg1-myc under its endogenous promoter,
we found that Brg1 binding to the promoters of hypha-specific
Figure 2. Brg1 interacts with Hda1 in vivo and binds to promoters of hypha-specific genes. (A). Cells of wild type transformed with Myc-
Brg1 and Hda1-Protein A (HLY4081) or with only Myc-Brg1 (HLY3636) were grown in YEPMaltose medium at 25uCo r3 7 uC in the presence or absence
of 10 nM rapamycin. Protein lysates were subjected to immunoprecipitation with IgG beads (Sigma). The precipitated proteins (IP) and cell lysates
(input) were analyzed by Western blotting. (B). Brg1 is present at the HWP1 promoter in a rapamycin-containing medium. Cells of wild-type strain
carrying Brg1-Myc (HLY4082) were diluted into YPD medium at 37uC in the presence or absence of 10 nM rapamycin. ChIP DNA was quantitated by
qPCR as described in Figure 1. The ChIP data show the average of three independent qPCR experiments with error bars representing the SEM.
doi:10.1371/journal.ppat.1002663.g002
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However, BRG1 expression also required rapamycin (Figure 3AB),
which could lead to the rapamycin-dependent promoter binding
observed with Brg1-myc under its own promoter (Figures 2B &
3D). Since BRG1 expression also requires the initial removal of
Nrg1 and subsequent binding of Brg1 (Figure 3B) similar to
hypha-specific promoters, we wanted to examine whether Brg1
DNA binding is under the control of Tor1. Ectopically expressed
Brg1-myc under the MAL2 promoter was used in ChIP
experiments to circumvent the Tor1 effects on BRG1 expression.
Unexpectedly, we found that Brg1 could bind to several promoters
of hypha-specific genes at 37uC independent of rapamycin
(Figures 4A and S7). Interestingly, Brg1 could not bind to its
own promoter without rapamycin at 37uC (Figure 4B). Nrg1 was
not responsible for the Tor1-regulated Brg1 binding, as the
association of Brg1 to its own promoter was still rapamycin
dependent in the nrg1 mutant (Figure 4B). Our data show that
reduced Tor1 signaling is required for the positive feedback
activation by Brg1 on its own promoter. Tor1 signaling does not
regulate Brg1 nuclear localization, its interaction with Hda1, or its
binding to the UAS regions of hypha-specific genes.
Ectopically expressed Brg1 does not bind to the
promoters of hypha-specific genes in yeast cells
Nrg1 can bind to promoters of hypha-specific genes in yeast
cells but not in hyphal cells [18]. Brg1 binds to the promoters in
hyphal cells to sustain hyphal development through Hda1
recruitment (Figure 2B). However, the lack of promoter-bound
Brg1 in yeast cells could be due to low levels of Brg1 protein, as
BRG1 expression is activated during hyphal elongation (Figure 3).
To examine whether Brg1 can bind the promoters of hypha-
specific genes in yeast cells, ChIP was performed in yeast cells
carrying ectopically expressed Brg1. As shown in Figure 4A,
Brg1 could not bind to the UAS region at the HWP1 promoter
in yeast cells at 25uC (Figure 4A). In contrast, Brg1 could bind to
the HWP1 promoter at 37uC (Figure 4A), a condition where
Nrg1 was temporarily removed [18]. Similarly, Brg1 could also
bind to the UAS regions of ECE1 and ALS3 promoters at 37uC,
but not at 25uC (Figure S7). Growth at 37uC was required to
clear Nrg1 because Brg1 could bind to the promoters in the nrg1
mutant regardless of temperature (Figure 4A). Therefore,
promoters of hypha-specific genes are not accessible to Brg1 in
yeast cells.
Ectopically expressed Brg1 can sustain hyphal growth in
the absence of rapamycin
Since reduced TOR signaling sustains hyphal growth through
the activation of BRG1 expression, we examined whether
overexpression of BRG1 could bypass the requirement of
rapamycin in sustained hyphal development. Ectopic expression
of BRG1 in a wild-type strain could sustain hyphal growth at 37uC
independent of rapamycin (Figure 4C). This functional assay
Figure 3. BRG1 expression is controlled by both removal of Nrg1 repression and rapamycin-dependent activation. qRT-PCR analysis of
BRG1 expression in wild type (A) and in the nrg1 mutant (B). Cells were diluted 1:250 fold into pre-warmed YPD medium at 25uCo r3 7 uC in the
presence or absence of 10 nM rapamycin. BRG1 mRNA levels were determined by qRT-PCR. The signals obtained from ACT1 mRNA were used for
normalization. The 0 h normalized value of BRG1/ACT1 for the wild type was set to be 1.00, and used for normalization of all other values in A and B.
ChIP time courses of Nrg1-Myc (HLY3922) and Brg1-Myc (HLY4082) are shown in C and D, respectively. Cells were diluted into YEPD medium at 37uC
in the presence or absence of 10 nM rapamycin. ChIP DNA were quantitated by qPCR with primers at 21959,21710 bp of the BRG1 promoter as
described in Figure 1. All data show an average of three independent qRT-PCR or qPCR experiments with error bars representing the SEM.
doi:10.1371/journal.ppat.1002663.g003
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directly regulate hypha-specific transcription.
We also observed that overexpressing Brg1 at 25uC could not
induce hyphal development (Figure 4C), consistent with the result
that Brg1 could not bind to promoters of hyphal genes and BRG1
in yeast phase (Figure 4AB). Although ectopic expression of Brg1
did not induce robust hyphal development after 6 hours, a few
cells became elongated. The low percentage of elongated cells
from ectopic Brg1 expression in yeast condition was in contrast to
its ability to sustain hyphal development in the absence of
rapamycin. Therefore, Brg1’s function is to sustain hyphal
development and Tor1 signaling controls hyphal elongation
through the regulation of BRG1 expression.
Nucleosome positions determine promoter accessibility
to Nrg1 and Brg1 in yeast and hyphal states
Nucleosomes are generally inhibitory to transcription factor
binding, and changes in nucleosome position are associated with
changes in gene expression by affecting the accessibility of
transcription factors to promoters [31,32]. We suspected that
changes in nucleosome positioning during yeast-to-hypha devel-
opment determined the differential promoter accessibility to Nrg1
and Brg1 in yeast and hyphal cells. To test this hypothesis, we
mapped nucleosome positions around the UAS region of the
HWP1 promoter with cells in yeast phase, during hyphal initiation,
during hyphal elongation with and without rapamycin, or with
ectopic expression of Brg1 (Figure 5A). We observed a nucleosome
free region (NFR) in the middle of the UAS region on the HWP1
promoter in yeast phase cells from the starting culture at 0 hours.
After 0.5 hours of hyphal induction in YPD at 37uC, the two
nucleosomes surrounding the NFR disappeared, leaving a large
region without nucleosomes. Interestingly, the two nucleosomes
stayed off in the hyphal cells after 4 hours of growth in YPD at
37uC, a condition in which BRG1 expression is low. During
sustained hyphal growth in the presence of rapamycin for BRG1
expression, or when Brg1 was ectopically expressed, a new
nucleosome appeared in the middle of the UAS region, leaving
two NFRs around the nucleosome. Our nucleosome mapping
experiments demonstrated changes in nucleosome positioning at
the UAS region of the HWP1 promoter during yeast-to-hypha
development: from two nucleosomes in yeast phase, to no
nucleosomes in the initiation phase, to one nucleosome in the
hyphal phase. The observed changes in nucleosome occupation at
the UAS region are consistent with our previous findings. Removal
of Nrg1 during hyphal induction leads to rapid histone
disassembly on UAS regions of hyphal genes [18], which correlates
to the dissociation of the two nucleosomes around the NFR in the
UAS of the HWP1 promoter. The formation of a new nucleosome
during hyphal elongation requires Brg1 binding and the
recruitment of Hda1, consistent with the finding that Hda1 at
the promoters leads to eviction of the NuA4 acetyltransferase
module and chromatin remodeling [18].
DNA sequence analysis for potential Nrg1 and Brg1 binding
motifs in the UAS region of the HWP1 promoter identified one
Nrg1 binding site and one Brg1 binding site. Interestingly, the
Nrg1 binding site is located in the NFR in yeast cells; therefore it
should be accessible to Nrg1 binding. However, the Brg1 binding
site is occupied by a nucleosome, making it not accessible to Brg1
(Figure 5A, 0 hour). During sustained hyphal development, the
Nrg1 binding site is occupied by a nucleosome and becomes
inaccessible whereas the Brg1 binding site is exposed in NFRs
(Figure 5A, +Rapa or MAL2p-BRG1). Both binding sites are
accessible during the hyphal initiation phase (Figure 5A, 0.5 hour).
Our data suggest that changes in nucleosome positioning during
the yeast-to-hypha development underlie the differences in
promoter accessibility to Nrg1 and Brg1. Consistent with the
concept that nucleosomes are inhibitory to transcription factor
binding, Nrg1 binding motifs are found in nucleosome free regions
upstream of repressed genes by genome-wide nucleosome
mapping of the yeast form of C. albicans [32]. Furthermore,
Figure 4. Ectopically expressed Brg1 sustains hyphal transcrip-
tion independent of rapamycin, but cannot bind the HWP1 or
BRG1 promoters in yeast cells. Ectopically expressed Brg1 could not
bind to the HWP1 promoter (A) or the BRG1 promoter (B) when Nrg1
was present. Cells of wild type (HLY3636) and nrg1 (HLY4080) carrying
Brg1-Myc under the MAL2 promoter were diluted into YEPMaltose
medium at 25uCo r3 7 uC in the presence or absence of 10 nM
rapamycin for 6 h. ChIP DNA was quantitated by qPCR as described in
Figure 3. All data show the average of three independent qRT-PCR or
qPCR experiments with error bars representing the SEM. (C). Cells of
wild type carrying Myc-Brg1 under the MAL2 promoter were diluted
1:250 fold into YEPMaltose medium at 25uCo r3 7 uC for 6 h in the
presence or absence of 10 nM rapamycin.
doi:10.1371/journal.ppat.1002663.g004
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BRG1, HWP1, ALS3 and ECE1 identified many Brg1 and Nrg1
binding motifs, but only the UAS regions are bound by Nrg1 in
yeast cells and by Brg1 in hyphal cells (Figures S6 and S8ABC).
Interestingly, all UAS regions of these promoters contain both
Nrg1 and Brg1 binding motifs. In addition, Brg1 also binds to the
promoters of two hypha-specific regulatory genes, UME6 and
HGC1, during hyphal elongation (Figure S9AB). Consistent with
other hyphal regulated genes, Brg1-bound regions on the two
promoters contain both Nrg1 and Brg1 binding sites within the
distance of a nucleosome, and regions with only Brg1 binding
sequence are not bound by Brg1 (Figure S9AB). All these support
the model that dynamic changes in nucleosome positioning on
promoters of hypha-specific genes during the yeast-to-hypha
transition lead to different accessibilities of these promoters to
Nrg1 and Brg1.
Our results infer that Brg1 mediates its effects by binding
directly to its binding sites at nucleosome free regions on the
promoters of many hypha-specific genes. To examine the
functionality of the putative Brg1 binding site in the UAS region
for HWP1, we replaced the Brg1 binding sequence AGGTAA at
21130 to 21125 on the HWP1 promoter with CTAGCC. The
mutated HWP1 promoter was introduced to a wild-type C. albicans
strain, generating a strain that carries both the wild-type HWP1
promoter and a copy of the HWP1 promoter mutated at the
putative Brg1 binding site. ChIP of Brg1 under a condition of
hyphal elongation showed the mutated HWP1 UAS region was
not associated with Brg1 in comparison to the wild type copy of
the HWP1 promoter in the same cells (Figure 5B). Therefore, the
predicted Brg1 binding site in the UAS region (21130 to 21125)
is directly responsible for Brg1 recruitment.
Ume6 functions after Brg1 in a positive feedback
regulation of hypha-specific genes to sustain hyphal
development
Ume6 has been shown to control the level and duration of
hypha-specific genes and is important for hyphal elongation [9–
11]. To address the functional relationship between Ume6 and
Hda1 recruitment by Brg1 in hyphal maintenance, we performed
a time course ChIP experiment of Hda1-Myc in brg1 and ume6
mutants. Unlike Brg1, Ume6 was not essential for promoter
recruitment of Hda1, although levels of promoter-associated Hda1
decreased in the ume6 mutant compared to that in the wild-type
strain (Figure 6A). Similar to other hypha-specific genes, UME6
expression is dependent on Brg1 and Hda1 (Figure 6B). However,
protein levels of Ume6 increased much slower and reached a
much lower level during hyphal induction in the absence of
rapamycin than expected (Figure 6C). Unstable UME6 transcript
or protein likely made Ume6 level sensitive to the level of UME6
expression and rendered Ume6 protein level more dependent on
Brg1 function than other proteins specifically expressed in hyphal
cells. We then examined whether overexpression of UME6 could
bypass the requirement of Hda1 in hyphal elongation. As shown in
Figure 6D, constitutively expressed Ume6, but not Brg1, restored
the hyphal growth defect in hda1 mutant cells. This result strongly
suggests that expressing UME6 is a major function of Brg1-
mediated chromatin remodeling by Hda1 during hyphal elonga-
tion. We further showed that Ume6 binds directly to the UAS
region of the HWP1 promoter (Figure 6C). Interestingly, levels of
promoter-bound Ume6 peaked later than Brg1 during hyphal
induction (Figure 6C vs. 2B). Based on our data, we suggest that
Ume6 functions directly on the promoters of hypha-specific genes
after Brg1 as a built-in positive feedback for sustained hyphal
development.
Figure 5. Nucleosome mapping analysis at the UAS region of
the HWP1 promoter indicates different promoter accessibility
to Nrg1 and Brg1 in yeast and hyphal cells. Overnight cultures of
wild type (SN250) cells were diluted 1:100 fold into YPD medium in the
presence or absence of 10 nM rapamycin at 37uC. Cells of wild type
carrying MAL2p-BRG1 (HLY3636) were diluted 1:100 fold into YPMaltose
medium at 37uC. Cells were collected at indicated times and conditions
for nucleosome mapping analysis. PCR primer pairs were designed to
generate ,100 bp fragments, with ,60 bp overlapping and a 40 bp
gap between neighboring PCR fragments. The x-axis represents the
midpoints of qPCR reactions. The signals from genomic DNA from each
sample for each primer pair were used for normalization. Data show the
average of three independent qPCR experiments with error bars
representing the SEM. Putative binding sites of Nrg1 (21284,21279)
and Brg1 (21130,21125) in the UAS region of the HWP1 promoter are
marked. (B). The predicted Brg1 binding motif in the UAS region of the
HWP1 promoter is required for Brg1 binding. An overnight culture of
HLY4079 (carrying both the WT HWP1 promoter and a copy of the
HWP1 promoter mutated at the Brg1 binding site) was inoculated at a
1:100 dilution into YPD medium in the presence of 10 nM rapamycin at
37uC for 4 h. Primers 21 and 22 were used to quantitate the binding of
Brg1 to the WT HWP1 promoter over no tag control, and primers 21 and
23 were used to quantitate the binding of Brg1 to the mutated HWP1
promoter over no tag control.
doi:10.1371/journal.ppat.1002663.g005
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Here we report the identification of Brg1, by a forward genetic
screen, as the transcription factor that recruits Hda1 to promoters
of hypha-specific genes under reduced Tor1 signaling for sustained
hyphal development. Many signaling pathways and transcription
factors play a role in hyphal morphogenesis in C. albicans. This is
evident from the vast literature on this topic and number of genes
implicated in hyphal morphogenesis [33]. In addition, large-scale
mutant screens have also identified many regulators of hyphal
morphogenesis including Brg1 [27,28]. A challenge is how to
dissect the complicated regulatory network and understand the
underlying molecular mechanisms for each regulator or pathway
in hyphal development. Our recent study suggests that hyphal
development undergoes two phases of regulation in promoter
chromatin: initiation and elongation [18]. Nrg1 is temporally
removed upon activation of the cAMP pathway during initiation;
Hda1 is recruited to the promoters of hypha-specific genes under
reduced Tor1 signaling during elongation. With this as our
framework, we find that, among 165 putative transcription factor
mutants, 7 mutants are defective in germ tube formation, and 47
mutants in hyphal elongation to different extents. Among the 47
mutants, 8 are still defective in the presence of rapamycin. Some of
the 8 regulators may act downstream of Tor1 signaling. Out of the
8 mutants, we further narrowed it down to brg1 as the only mutant
defective in the promoter recruitment of Hda1. Consistent with
the mutant phenotype, we find that Brg1 interacts with Hda1.
Furthermore, it binds to the promoters of hypha-specific genes
during hyphal elongation in a rapamycin-dependent manner.
Therefore, by separating defects in hyphal initiation vs. elongation,
and by examining whether rapamycin could bypass the defects, as
well as by using Nrg1 protein level and Hda1 promoter
recruitment as readouts, we are able to identify one, from many
mutants defective in hyphal development, that is specifically
involved in Hda1 promoter recruitment. We also find that ahr1
and rob1 mutants are partially defective in hyphal development
Figure 6. Ume6 functions downstream of Brg1 and Hda1 in hyphal maintenance. (A). Ume6 is not essential for promoter recruitment of
Hda1 during hyphal elongation. ChIP of Hda1-Myc in wild type, brg1, and ume6 mutants in YPD with 10 nM rapamycin at 37uC. (B). UME6 expression
requires Brg1 and Hda1. Expression levels were quantified by qRT-PCR and normalized with ACT1. All data show the average of three independent
qRT-PCR or qPCR experiments with error bars representing the SEM. (C). Ume6 binds to hyphal promoters during hyphal elongation. ChIP and
Western analysis of Ume6 in wild type cells (HLY4078) in indicated media. (D). Ectopic expression of UME6, but not BRG1, restores filamentous growth
in the hda1 mutant. hda1 cells transformed with pBES116 (V), MAL2p-MYC-BRG1 (HLY4077) or MAL2p-UME6-MYC (HLY4076) were grown in
YEPMaltose medium with 5 nM rapamycin for cell morphology.
doi:10.1371/journal.ppat.1002663.g006
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previously shown to function in hyphal development [27,34]. It
is a zinc-finger transcription factor that recruits Mcm1 to
promoters of genes involved in biofilm formation, filamentous
growth, etc. including EFG1 and NRG1 [34]. Based on our data
and Ahr1 target genes [34], Ahr1 likely affects hyphal develop-
ment through the regulation of EFG1 and/or NRG1 expression.
Our forward genetic screening demonstrates that this scheme of
mutant analyses can provide a framework for further character-
ization of other mutants defective in hyphal development.
BRG1 expression is a sensitive output of Tor1 signaling in C.
albicans. Sustained hyphal development requires only a sub-growth
inhibitory level of 5–10 nM rapamycin [18]. This is 10-fold lower
than the concentration required for nuclear localization of the
GATA transcription factors Gln3 and Gat1 in S. cerevisiae [23].
Similarly, we have observed nuclear localization of Gln3 in C.
albicans only in the presence of 100 nM rapamycin, but not at
10 nM (our unpublished data). In contrast to Gln3, Brg1 nuclear
localization is not regulated by rapamycin. Instead, BRG1
expression requires the presence of 5–10 nM rapamycin, making
it a sensitive readout of Tor1 signaling. In addition to reduced
Tor1 signaling, activation of BRG1 expression also requires the
removal of Nrg1 inhibition. This is different from hypha-specific
genes where lack of Nrg1 is sufficient for their expression.
Therefore, BRG1 expression uses an AND gate logic gating for
signal integration. This type of logic gating is also seen in other
GATA factor regulated gene expression. For example, the
expression of nitrate and nitrite reductase in Aspergillus nidulans
requires both the presence of nitrate and the absence of
ammonium and glutamine [35]. Nrg1 and Brg1 act directly on
the BRG1 promoter. Similar to hyphal specific promoters, Nrg1
dissociates from the BRG1 promoter during hyphal initiation and
subsequently, Brg1 binds to the promoters during hyphal
elongation in a rapamycin-dependent manner. Brg1 protein is
not a direct target of the Tor1 pathway because Brg1 association
with hypha-specific promoters is independent of rapamycin and
ectopic expression of Brg1 can sustain hyphal elongation in the
absence of rapamycin. Therefore, Tor1 function in hyphal
development is through the transcriptional regulation of BRG1.
Experiments are underway to identify the additional regulators of
BRG1 expression.
The position of nucleosomes in a gene promoter impacts the
accessibility of transcription factors to their DNA-binding sites.
Ectopically expressed Brg1 binds promoters of hypha-specific
genes only in hyphal cells, but not in yeast cells. Conversely, Nrg1
binds to the promoters in yeast cells, but not in hyphal cells. By
mapping nucleosome positions during yeast-to-hypha develop-
ment at the UAS region of the HWP1 promoter, we find dynamic
changes in nucleosome positioning at the UAS region. The
observed change in nucleosome positioning provides a mechanism
for differential accessibility to Nrg1 and Brg1 in yeast and hyphal
cells. Other hypha-specific promoters, including UME6 and HGC1
as well as BRG1, likely have different nucleosome positioning in
yeast and hyphae similar to HWP1 as differential Brg1 and Nrg1
binding is observed for all hypha-specific promoters examined.
Furthermore, Brg1 bound regions on the examined promoters all
have both Brg1 and Nrg1 binding sites within the distance of one
nucleosome. We propose that hyphal development undergoes
sequential changes in nucleosome positioning from the yeast state,
to a transition state, and then to the hyphal state (Figure 7). In the
yeast state Nrg1 binding sites are in a nucleosome free region and
accessible, whereas Brg1 bindings sites are occupied by nucleo-
somes and therefore not accessible. Upon activation of the cAMP/
PKA pathway when cells are inoculated into fresh media at 37uC,
Nrg1 is temporarily removed, leading to rapid nucleosome
disassembly at the UAS regions [18]. During the transition state,
binding sites for both Nrg1 and Brg1 are accessible, providing a
time window for Brg1 accumulation and binding to promoters
before Nrg1 returns. In the hyphal state, nucleosomes reposition
through Brg1-mediated Hda1 recruitment and chromatin remod-
eling, thus the Nrg1 binding sites are not accessible. The precise
positions of Brg1 binding sites relative to nucleosomes in the
hyphal state may vary among the promoters as they differ in levels
or extent of expression during hyphal development. This effect of
nucleosome positions on transcription factor binding and tran-
scription induction is convincingly demonstrated by the Pho5
system in S. cerevisiae [36]. On the other hand, nucleosome
occupancy is dynamic and is determined by a balance of assembly
and disassembly activities. When highly expressed, Brg1 can
compete with nucleosomes and convert some cells from the yeast
to hyphal state. This is a slow and occasional event, consistent with
the existence of a few elongated cells in a culture of mostly yeast
cells when Brg1 is expressed from the MAL2 promoter under yeast
growth conditions. A change in nucleosome positioning during
yeast-to-hypha development provides a molecular mechanism for
temporally linked regulation of promoter chromatin. It also
provides a mechanism for plasticity in hyphal development and
explains cell-to-cell variation among a cell population, which is
important for adaptation and survival of unicellular microorgan-
isms in stress conditions.
The function of Brg1 in hyphal development is to recruit Hda1
to the UAS regions of hypha-specific promoters. Hda1 in turn
remodels promoter chromatin by deacetylating a subunit of the
NuA4 histone acetyltransferase module, leading to the occlusion of
Nrg1 binding sites [18]. We have also shown that hyphal induction
either in the presence of rapamycin, a condition for BRG1
expression or with the ectopic expression of Brg1, leads to
nucleosome repositioning. This function of Brg1 in chromatin
Figure 7. A schematic diagram depicting temporal dynamic
regulation of promoter chromatin during the yeast-to-hypha
transition. Hyphal development undergoes sequential changes in
nucleosome positioning from the yeast state, to a transition state, and
then to the hyphal state by changing promoter accessibility to Nrg1
and Brg1. Black lines represent active regulatory relationships; gray lines
represent relationships that are inactive; dashed lines represent
relationships that are not yet determined. Dashed circles represent
degraded proteins. HSG, hypha-specific genes.
doi:10.1371/journal.ppat.1002663.g007
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been shown to play a role in nucleosome rearrangements [35,37–
39]. The ultimate function of Brg1 in chromatin rearrangement
during hyphal development is to remove Nrg1 inhibition. This
provides another layer of Nrg1 regulation, in addition to
regulating its expression and stability. The additional layer of
regulation provides C. albicans with a flexible response to nutrition
and various growth environments.
One key downstream target of the Brg1-mediated chromatin
regulation is UME6. Brg1 binds upstream of UME6, and UME6
expression depends on Brg1 and Hda1. Furthermore, ectopic
expression of Ume6 completely bypassed the requirement of Brg1
or Hda1. In this sense, hypha-specific expression of some genes
could be regulated indirectly by Brg1 through the control of the
level of Ume6. Our results demonstrate that Ume6 functions after
Brg1 and Hda1 as a built-in positive feedback regulation of the
hyphal transcriptional program to sustain hyphal development,
consistent with its reported functions [9–11]. We suggest that the
yeast-to-hypha transition is controlled by a feed-forward loop of
regulations by Nrg1, Brg1, and Ume6. This temporal regulatory
model is in agreement with delayed hyphal development by
ectopic expression of Ume6 in yeast growth conditions [10]. Brg1
plays a critical function as a mid-regulator in this feed-forward
loop. It provides C. albicans with a means to sense and integrate
multiple nutritional and environmental signals for control of its
morphological program that is essential for its pathogenesis.
Considering that misregulation of either Nrg1 or Ume6 level
causes altered virulence [9,40], our identification of Brg1 as an
output of the Tor1 signaling that regulates Nrg1 binding and
Ume6 expression should provide a better understanding of the
molecular mechanisms that control the yeast-hyphal development
in its hosts, and how C. albicans senses and integrates multiple
nutritional and environmental signals in the host for its adaption to
exist as both a commensal and pathogen.
Materials and Methods
Screening of transcription factor mutants defective in
hyphal elongation
165 putative transcription factor mutants [27] and the wild-type
reference strain SN250 were grown overnight in liquid YPD at
30uC. 15 mutants grew as elongated pseudohyphae and they were
excluded from further analysis. The remaining 150 mutants and
wild type cells were diluted at 1:100 to YPD+10% Serum at 37uC
for 1 h for a germ tube formation screen. 14 mutants were
defective in germ tube formation. Among them, 7 completely
blocked germ tube formation and were excluded. For mutants
defective hyphal elongation, the 143 remaining mutants were
grown in Lee’s medium for 6 h at 37uC, and 47 mutants were
defective in hyphal elongation. Among these 47 mutants, 39
mutants could be restored in hyphal elongation by rapamycin in
YPD at 37uC. Only 8 transcription factor mutants were defective
in response to rapamycin induced hyphal maintenance.
Plasmid and strain construction
The C. albicans strains used in this study are listed in Table S1.
Primer sequences are listed in Table S2. The 8 transcription
mutants defective in rapamycin induced hyphal elongation and
UZ43 [11] were streaked on 5-fluoro-orotic acid-containing
medium to generate Ura
– strains for these mutants. pPR673-
HDA1 was digested with BamHI to target the integration of the
plasmid into the HDA1 locus to express Hda1-13Myc in these
mutants. A 1.2-kb PCR product (primers 1 and 2) containing the
C-terminal BRG1 coding region was inserted into the BamHI-MluI
sites of pPR671 and pPR673 [30]. The resulting plasmids were
digested with SpeI for target integration into the BRG1 loci to
express Brg1-13Myc. The pMAL2-MYC-BRG1 plasmid was
constructed by amplifying BRG1 (primers 3 and 4) to replace
HGC1 from the pMAL2-MYC-HGC1 plasmid [41]. The resulting
plasmid was digested with AscI to target integration into the ADE2
locus to express Brg1-13Myc. A 1.3-kb PCR product (primers 5
and 6) containing the C-terminal HDA1 coding region was
digested with BglII and MluI to replace CPH1 from the pACT1-
CPH1-TAP plasmid (our unpublished data). The resulting plasmid
was digested with BamHI to target the integration of the plasmid
into the HDA1 locus in HLY3636 to express Hda1-TAP. The
pMAL2-UME6-13MYC plasmid was constructed by amplifying
UME6 (primers 7 and 8) to replace NRG1 from the pMAL2-
NRG1-MYC plasmid. The resulting plasmids were digested with
AscI for target integration into the ADE2 locus in HLY4032 to
express Ume6-13Myc. To construct a mutant HWP1 promoter
with a site-specific mutation at the predicted Brg1 binding site in
the UAS region, the AGGTAA sequence at 21130 to 21125
upstream of HWP1 was replaced by CTAGCC. Two pairs of
primers (primers 17 and 18, 19 and 20) were used to PCR amplify
overlapping HWP1 promoter fragments with the mutation in the
overlapping region. The resulting PCR products were purified and
mixed as templates for another round of PCR amplification using
the primers 17 and 20, which produced the full-length mutated
HWP1 promoter sequence. The resulting PCR product was cloned
into the KpnI-ClaI site of the plasmid pHL471 [42] to express
GFP, and was confirmed by DNA sequencing. The resulting
plasmid was digested with BglII within the HWP1 promoter region
(from 21465 to 21460) for integration into the endogenous
HWP1 promoter locus. Primers 21 and 22 were used to quantitate
the binding of Brg1 to the wild type HWP1 promoter, and primers
21 and 23 were used to quantitate the binding of Brg1 to the
mutated HWP1 promoter.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as described
with modifications [30]. DNA was sheared by sonication six times
for 20 seconds at high power on a Bioruptor (diagenode) with
40 second intervals on ice. 10 ml of anti-Myc (SC-789, Santa Cruz)
antibodies were used for ,4 mg of chromatin proteins in an
immunoprecipitation volume of 200 ml.
Immunoprecipitation
Protein extraction and immunoprecipitation were performed as
described previously (Cao et al., 2006) with modifications. Protein
extract containing 10 mg protein were subjected to immunopre-
cipitation using 60 ml of immunoglobulin G (IgG) agarose bead
slurry (Sigma), which was preincubated once with 0.2 mg/ml
sheared salmon sperm DNA, 0.5 mg/ml bovine serum albumin in
phosphate-buffered saline. Proteins were separated by 8% SDS-
polyacrylamide gel electrophoresis and transferred to a polyviny-
lidene difluoride membrane (Hybond; GE Healthcare). After
blocking in 3% skim-milk powder in Tris-buffered saline/0.05%
Tween 20, a peroxidase-conjugated anti-c-Myc antibody (Roche)
was used to probe for Myc-tagged proteins, which were then
detected using the enhanced chemiluminescence system (Pierce
Chemical. Rockford, IL).
Quantitative PCR expression analysis
Methods for RNA isolation were carried out as previously
described [43]. 10 mg of total RNA was DNase-treated at 37uC for
1 h using the DNase-free kit (Qiagen), cDNA was synthesized
using the SuperScript II Reverse Transcriptase kit (Invitrogen),
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Rad) using the primers 9 and 10 for BRG1, primers 11 and 12 for
ACT1 and primers 13 and 14 for UME6.
Nucleosome mapping
For the MNase assay, we used the protocol described as
previously described [44,45]. In brief, we harvested 5610
7 cells of
each sample, and washed in 1 ml water. Then we resuspended the
cells in 1 ml of sphaeroplasting solution (1 M sorbitol, 0.5 mM 2-
mercaptoethanol, 0.18 mg/ml zymolyase), and incubated at room
temperature for 5 min with gentle stirring. We harvested the cells,
washed it in 1 ml of 1 M sorbitol, then resuspended the pellet in
500 ml of digestion buffer (1 M sorbitol, 50 mM NaCl, 100 mM
Tris-Cl [pH 7.4], 5 mM MgCl2, 1 mM CaCl2, 1 mM 2-
mercaptoethanol, 0.5 mM spermidine, 0.075% NP-40, micrococ-
cal nuclease with a final concentration 1–10 U/ml) for 8 min at
37uC. After terminating the MNase digestion by adding 50 ml
quench buffer (250 mM EDTA, 5% SDS), DNA was extracted
with phenol/chloroform, and then we proceeded with the qPCR
analysis. The PCR product was designed to be ,100 bp, and the
neighboring PCR primers are ,40 bp apart. In the nucleosome
map, the x-axis represents the midpoint of the PCR product. The
signal of each primer pair obtained from genomic DNA from each
sample was used for normalization. The values of nucleosome
occupancy at 25188 on the WOR1 promoter, which is not
regulated by the yeast-hypha transition, were set to be 1.00.
Supporting Information
Figure S1 Brg1 is required for hyphal elongation and
promoter recruitment of Hda1 in serum-containing
media. (A). Wild type and brg1 mutant cells were inoculated
into YPD+10% serum medium at 37uC and grown for 4 h. (B).
Wild type and brg1 mutant cells carrying Hda1-Myc were
inoculated into YPD+10% serum at 37uC and grown for 3 h.
ChIP DNA was quantitated with primers at the UAS region of
HWP1.
(TIF)
Figure S2 Recruitment of Hda1 to promoters of ALS3
and ECE1 in the presence rapamycin is Brg1 dependent.
Wild type and brg1 mutant cells carrying Hda1-Myc were
inoculated into YPD+10 nM rapamycin medium at 37uC and
grown for 6 h, as described in Figure 1. ChIP DNA was
quantitated with primers at the UAS regions of ALS3 and ECE1
using primers described in [30], and the region 2672,2447 of
the ALS3 promoter that contains a GATA factor binding site.
(TIF)
Figure S3 Brg1 is constitutively localized in the nucleus.
Wild-type strain expressing Myc-Brg1 under the MAL2 promoter
(HLY3636) was grown in YPD medium at 37uC in the presence or
absence of 10 nM rapamycin. Cells were fixed at 3 h after
inoculation and processed for indirect immunofluorescence with a
method as described [41] with 9E10 mouse antibodies and FITC-
conjugated secondary antibodies. DNA was stained with DAPI.
An untagged control (SC5314) was included.
(TIF)
Figure S4 Western analysis of Brg1 in YPD medium
with or without rapamycin at 256Co r3 7 6C. (A) Wild-type
cells carrying Brg1-Myc (HLY4059) were diluted into the
indicated media and conditions, and cells were collected at
0 min, 1 h, 3 h, and 5 h for Western analysis. (B) Brg1 protein
stability is not regulated by rapamycin. Western of wild-type cells
carrying Myc-Brg1 under the MAL2 promoter inoculated from
overnight culture into fresh YPD medium at 25uCo r3 7 uC in the
presence or absence 10 nM rapamycin.
(TIF)
Figure S5 Constitutively expressed NRG1 blocks BRG1
activation. Cells of wild type or the nrg1 mutant carrying
MAL2p-Nrg1-Myc, from overnight cultures in YEP Maltose at
30uC, were inoculated at 1:20 dilution into YEP Maltose at 37uC
in the presence of 10 nM rapamycin and grown for 1 h. BRG1
mRNA levels were determined by RT-PCR as Fig. 3A.
(TIF)
Figure S6 ChIP of Nrg1 and Brg1 at different regions of
the BRG1 promoter. Wild-type cells carrying Nrg1-Myc or
Brg1-Myc were grown in YPD medium at 25uC or YPD+10 nM
rapamycin at 37uC, respectively, for 6 h. SC5314 was used as a no
tag control. The enrichment over that of untagged controls is
shown. Locations of specific sequence elements are marked (Nrg1
sites [green]: [A/C][A/C/G]CCCT, CCCCT, or CCCTC [20].
Brg1 sites [red]: [A/C]GGTA[C/A] [46]. Positions of primer
pairs are indicated in rectangles.
(TIF)
Figure S7 Ectopically expressed Brg1 could not bind to
hyphal promoters in yeast cells. ChIP of Myc-Brg1 under
the MAL2 promoter in wild-type cells grown in YEPMaltose
medium at 25uCo r3 7 uC for 6 h.
(TIF)
Figure S8 ChIP of Brg1 at different regions of hyphal
promoters. Wild-type cells carrying Brg1-Myc were grown in
YPD+10 nM rapamycin at 37uC for 6 h. SC5314 was used as a no
tag control. The enrichment over that of untagged controls is
shown. Locations of specific sequence elements are marked (Nrg1
sites [green]: [A/C][A/C/G]CCCT, CCCCT, or CCCTC [20].
Brg1 sites [red]: [A/C]GGTA[C/A]) [46]. Positions of primer
pairs used for qPCR are indicated and numbered. The UAS
region of each promoter is located in the dashed rectangle.
(TIF)
Figure S9 ChIP of Brg1 at different regions of UME6
and HGC1 promoters. Wild-type cells carrying Brg1-Myc were
grown in YPD+10 nM rapamycin at 37uC for 6 h. SC5314 was
used as a no tag control. Locations of specific sequence elements
are marked (Nrg1 sites [green]: [A/C][A/C/G]CCCT, CCCCT,
or CCCTC [20]. Gat2 sites [red]: [A/C]GGTA[C/A]) [46].
Positions of primer pairs used for qPCR are indicated and
numbered. The enrichment of Brg1 at the indicated regions
upstream of UME6 (A) and HGC1 (B) over that of untagged
control is shown.
(TIF)
Table S1 C. albicans strains used in this study.
(DOC)
Table S2 Primers used in this study.
(DOC)
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